Class II HLA alleles and hepatitis B virus persistence in African Americans

Journal of Infectious Diseases

Volumn 179, Issue 4, 1999, Pages 1004-1006

  Thio, Chloe L ^b   Carrington, Mary ^b   Marti, Darlene ^b   O'Brien, Stephen J ^b   Vlahov, David ^b   Nelson, Kenrad E ^b   Astemborski, Jacquie ^b   Thomas, David L ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2;

ADULT; ALLELE; ANTIGEN PRESENTATION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HAPLOTYPE; HEPATITIS B VIRUS; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PERSISTENT INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROLOGY;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; COHORT STUDIES; FEMALE; GENES, MHC CLASS II; HEPATITIS B; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MALE; PROSPECTIVE STUDIES;

EID: 0001624087     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314684     Document Type: Article

References (16)

1. Lee WM. Hepatitis B virus infection. N Engl J Med 1997;337:1733-45.
2. Doherty PC, Zinkernagel RM. Enhanced immunological surveillance in mice heterozygous at the H-2 gene complex. Nature 1975;256:50-2.
3. Hughes AL, Nei M. Pattern of nucleotide substitution at major histocompatibility complex class I loci reveals overdominant selection. Nature 1988;335:167-70.
4. Thursz M, Thomas HC, Greenwood BM, Hill AVS. Heterozygote advantage for HLA class-II type in hepatitis B virus infection. Nat Genet 1997;17: 11-2.
5. Thursz MR, Kwiatkowski D, Allsopp CEM, Greenwood BM, Thomas HC, Hill AVS. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med 1995;332:1065-9.
6. Hohler T, Gerken G, Notghi A, et al. HLA-DRB1*1301 and *1302 protect against chronic hepatitis B. J Hepatol 1997;26:503-7.
7. Almarri A, Batchelor JR. HLA and hepatitis B infection. Lancet 1994;344: 1194-5.
8. Descamps B, Jungers P, Naret C, Degott C, Zingraff J, Bach JF. HLA-A1,B8 phenotype association and HBs antigenemia evolution in 440 hemodialyzed patients. Digestion 1977;15:271-7.
9. Vlahov D, Anthony JC, Muñoz A, et al. The ALIVE study: a longitudinal study of HIV-1 infection in intravenous drug users: description of methods. J Drug Issues 1991;21:759-76.
10. Levine OS, Vlahov D, Nelson KE. Epidemiology of hepatitis B virus infections among injecting drug users: seroprevalence, risk factors, and viral interactions. Epidemiol Rev 1994;16:418-36.
11. Dean M, Stephens JC, Winkler C, et al. Polymorphic admixture typing in human ethnic populations. Am J Hum Genet 1994;55:788-808.
12. Tonks S, Marsh SGE, Bunce M, et al. HLA class I ONA typing study. In: Carron D, ed. Genetic diversity of HLA: functional and medical implication. Paris: EDK Medical and Scientific International, 1997;199-215.
13. Carrington M, Millter T, White ME, et al. Typing of HLA-DQA1 and DQB1 using DNA single-stranded conformational polymorphism. Hum Immunol 1992;33:208-12.
14. Just JJ, King MC, Thomson G, Klitz W. African-American HLA class II allele and haplotype diversity. Tissue Antigens 1997;49:547-55.
15. Mori M, Beatty PG, Graves M, Boucher KM, Milford EL. HLA gene and haplotype frequencies in the North American population. Transplantation 1997;64:1017-27.
16. Smith MW, Dean M, Carrington M, et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 1997;277:959-65.